 Connection
David Saxon to Humans
This is a "connection" page, showing publications David Saxon has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.221 |
|
|
|
-
Saxon D, Barkham M, Bee P, Gellatly J, Faija C, Bower P. Telephone treatments in Improving Access to Psychological Therapies services: an analysis of use and impact on treatment uptake. BMC Psychiatry. 2023 02 07; 23(1):95.
Score: 0.023
-
Saxon DR, Kaboli PJ, Haraldsson B, Wilson C, Ohl M, Augustine MR. Growth of electronic consultations in the Veterans Health Administration. Am J Manag Care. 2021 01; 27(1):12-19.
Score: 0.020
-
Saxon DR, Reiter-Brennan C, Blaha MJ, Eckel RH. Cardiometabolic Medicine: Development of a New Subspecialty. J Clin Endocrinol Metab. 2020 07 01; 105(7).
Score: 0.020
-
Saxon DR, Iwamoto SJ, Mettenbrink CJ, McCormick E, Arterburn D, Daley MF, Oshiro CE, Koebnick C, Horberg M, Young DR, Bessesen DH. Antiobesity Medication Use in 2.2 Million Adults Across Eight Large Health Care Organizations: 2009-2015. Obesity (Silver Spring). 2019 12; 27(12):1975-1981.
Score: 0.019
-
Saxon DR, Chaussee EL, Juarez-Colunga E, Tsai AG, Iwamoto SJ, Speer RB, Heyn H, Kealey EH, Bessesen DH. A Toolbox Approach to Obesity Treatment in Urban Safety-Net Primary Care Clinics: a Pragmatic Clinical Trial. J Gen Intern Med. 2019 11; 34(11):2405-2413.
Score: 0.018
-
Varela D, Yu A, Saxon D. Insulinoma Masquerading as Transient Neurocognitive Impairment. Am J Med. 2018 09; 131(9):e377-e379.
Score: 0.017
-
Saxon DR, Rasouli N, Eckel RH. Pharmacological Prevention of Cardiovascular Outcomes in Diabetes Mellitus: Established and Emerging Agents. Drugs. 2018 Feb; 78(2):203-214.
Score: 0.017
-
Saxon DR, Eckel RH. Statin Intolerance: A Literature Review and Management Strategies. Prog Cardiovasc Dis. 2016 Sep - Oct; 59(2):153-164.
Score: 0.015
-
Saxon DR, McDermott MT, Michels AW. Novel Management of Insulin Autoimmune Syndrome with Rituximab and Continuous Glucose Monitoring. J Clin Endocrinol Metab. 2016 05; 101(5):1931-4.
Score: 0.015
-
Stone NJ, Saxon D. Approach to treatment of the patient with metabolic syndrome: lifestyle therapy. Am J Cardiol. 2005 Aug 22; 96(4A):15E-21E.
Score: 0.007
-
Hoffner-Heinike A, Iwamoto SJ, Saxon DR, Cogdall NA, Davies RD, Lee RS, Chiappone A, Thomas JF, Rothman MS. ECHO "Bootcamp": An Innovative Training Model to Onboard Providers in the Care of Gender Diverse Patients. Telemed J E Health. 2024 Feb; 30(2):430-437.
Score: 0.006
-
Raghavan S, Warsavage T, Liu WG, Raffle K, Josey K, Saxon DR, Phillips LS, Caplan L, Reusch JEB. Trends in Timing of and Glycemia at Initiation of Second-line Type 2 Diabetes Treatment in U.S. Adults. Diabetes Care. 2022 06 02; 45(6):1335-1345.
Score: 0.006
-
Kheniser K, Saxon DR, Kashyap SR. Long-Term Weight Loss Strategies for Obesity. J Clin Endocrinol Metab. 2021 06 16; 106(7):1854-1866.
Score: 0.005
-
Barkham M, Saxon D, Hardy GE, Bradburn M, Galloway D, Wickramasekera N, Keetharuth AD, Bower P, King M, Elliott R, Gabriel L, Kellett S, Shaw S, Wilkinson T, Connell J, Harrison P, Ardern K, Bishop-Edwards L, Ashley K, Ohlsen S, Pilling S, Waller G, Brazier JE. Person-centred experiential therapy versus cognitive behavioural therapy delivered in the English Improving Access to Psychological Therapies service for the treatment of moderate or severe depression (PRaCTICED): a pragmatic, randomised, non-inferiority trial. Lancet Psychiatry. 2021 06; 8(6):487-499.
Score: 0.005
-
Glodowski M, Christen S, Saxon DR, Hegele RA, Eckel RH. Novel PPARG mutation in multiple family members with chylomicronemia. J Clin Lipidol. 2021 May-Jun; 15(3):431-434.
Score: 0.005
-
Thompson MA, Fuhlbrigge AL, Pearson DW, Saxon DR, Oberst-Walsh LA, Thomas JF. Building eConsult (Electronic Consults) Capability at an Academic Medical Center to Improve Efficiencies in Delivering Specialty Care. J Prim Care Community Health. 2021 Jan-Dec; 12:21501327211005303.
Score: 0.005
-
Salahuddin T, Richardson V, McNeal DM, Henderson K, Hess PL, Raghavan S, Saxon DR, Valle JA, Waldo SW, Ho PM, Schwartz GG. Potential unrealized mortality benefit of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transport-2 inhibitors: A report from the Veterans Health Administration Clinical Assessment, Reporting and Tracking program. Diabetes Obes Metab. 2021 01; 23(1):97-105.
Score: 0.005
-
Iwamoto S, Saxon D, Tsai A, Leister E, Speer R, Heyn H, Kealey E, Juarez-Colunga E, Gudzune K, Bleich S, Clark J, Bessesen D. Effects of Education and Experience on Primary Care Providers' Perspectives of Obesity Treatments during a Pragmatic Trial. Obesity (Silver Spring). 2018 10; 26(10):1532-1538.
Score: 0.004
-
Raghavan S, Liu WG, Michael Ho P, Plomondon ME, Bar?n AE, Caplan L, Joynt Maddox KE, Magid D, Saxon DR, Voils CI, Bradley SM, Maddox TM. Coronary artery disease severity modifies associations between glycemic control and both mortality and myocardial infarction. J Diabetes Complications. 2018 05; 32(5):480-487.
Score: 0.004
-
Liu W, Saxon DR, McNair B, Sanagorski R, Rasouli N. Endocrinology Telehealth Consultation Improved Glycemic Control Similar to Face-to-Face Visits in Veterans. J Diabetes Sci Technol. 2016 09; 10(5):1079-86.
Score: 0.004
-
Oyer DS, Saxon D, Shah A. Quantitative assessment of diabetic peripheral neuropathy with use of the clanging tuning fork test. Endocr Pract. 2007 Jan-Feb; 13(1):5-10.
Score: 0.002
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|